Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
80.42
+0.80 (1.00%)
At close: Jul 3, 2025, 1:00 PM
80.41
-0.01 (-0.01%)
After-hours: Jul 3, 2025, 4:45 PM EDT
Lantheus Holdings Market Cap
Lantheus Holdings has a market cap or net worth of $5.56 billion as of July 3, 2025. Its market cap has decreased by -2.85% in one year.
Market Cap
5.56B
Enterprise Value
5.24B
1-Year Change
-2.85%
Ranking
Category
Stock Price
$80.42
Market Cap Chart
Since June 25, 2015, Lantheus Holdings's market cap has increased from $178.90M to $5.56B, an increase of 3,010.08%. That is a compound annual growth rate of 40.87%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 3, 2025 | 5.56B | -10.55% |
Dec 31, 2024 | 6.22B | 46.48% |
Dec 29, 2023 | 4.25B | 21.06% |
Dec 30, 2022 | 3.51B | 79.37% |
Dec 31, 2021 | 1.96B | 116.78% |
Dec 31, 2020 | 902.10M | 12.06% |
Dec 31, 2019 | 805.00M | 33.72% |
Dec 31, 2018 | 602.00M | -21.51% |
Dec 29, 2017 | 767.00M | 149.67% |
Dec 30, 2016 | 307.20M | 188.72% |
Dec 31, 2015 | 106.40M | -40.53% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 699.59B |
Johnson & Johnson | 374.29B |
AbbVie | 336.94B |
Novo Nordisk | 309.43B |
UnitedHealth Group | 279.00B |
Novartis AG | 243.28B |
Abbott Laboratories | 233.33B |
AstraZeneca | 219.33B |